IL115652A - Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages - Google Patents

Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages

Info

Publication number
IL115652A
IL115652A IL11565295A IL11565295A IL115652A IL 115652 A IL115652 A IL 115652A IL 11565295 A IL11565295 A IL 11565295A IL 11565295 A IL11565295 A IL 11565295A IL 115652 A IL115652 A IL 115652A
Authority
IL
Israel
Prior art keywords
hemorrhages
vwf
antithrombotic
medicaments
fragments
Prior art date
Application number
IL11565295A
Other languages
English (en)
Other versions
IL115652A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL115652A0 publication Critical patent/IL115652A0/xx
Publication of IL115652A publication Critical patent/IL115652A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11565295A 1994-10-20 1995-10-18 Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages IL115652A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437544A DE4437544A1 (de) 1994-10-20 1994-10-20 Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika

Publications (2)

Publication Number Publication Date
IL115652A0 IL115652A0 (en) 1996-01-19
IL115652A true IL115652A (en) 2000-08-31

Family

ID=6531287

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11565295A IL115652A (en) 1994-10-20 1995-10-18 Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages

Country Status (20)

Country Link
US (1) US5571784A (cs)
EP (1) EP0713881A3 (cs)
JP (1) JPH08208504A (cs)
KR (1) KR960013383A (cs)
CN (1) CN1128168A (cs)
AU (1) AU708670B2 (cs)
CA (1) CA2160975A1 (cs)
CZ (1) CZ287878B6 (cs)
DE (1) DE4437544A1 (cs)
FI (1) FI954964A (cs)
HR (1) HRP950525A2 (cs)
HU (1) HU219595B (cs)
IL (1) IL115652A (cs)
NO (1) NO954175L (cs)
NZ (1) NZ280274A (cs)
PL (1) PL183182B1 (cs)
SK (1) SK129695A3 (cs)
TW (1) TW398977B (cs)
UY (1) UY24063A1 (cs)
ZA (1) ZA958838B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
JP2003284570A (ja) 2001-04-25 2003-10-07 Chemo Sero Therapeut Res Inst フォンビルブラント因子（ｖＷＦ）切断酵素
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
EP2536753B1 (en) * 2010-02-16 2017-12-20 Novo Nordisk A/S Factor viii molecules with reduced vwf binding
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
TWI580423B (zh) * 2013-12-24 2017-05-01 財團法人工業技術研究院 緩解或治療痛風之醫藥組合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2619314B1 (fr) * 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
US5204323B1 (en) 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
GB8823480D0 (en) 1988-10-06 1988-11-16 Ciba Geigy Ag Antidote
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
DE4115453A1 (de) 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
US5366869A (en) * 1991-11-08 1994-11-22 Sheldon Goldstein Multiple coagulation test device and method
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
WO1994025582A1 (en) * 1993-04-23 1994-11-10 Bio-Technology General Corp. Method of enhancing thrombolysis

Also Published As

Publication number Publication date
CZ287878B6 (cs) 2001-03-14
CA2160975A1 (en) 1996-04-21
NZ280274A (en) 1997-01-29
UY24063A1 (es) 1995-10-24
PL183182B1 (pl) 2002-06-28
FI954964A (fi) 1996-04-21
HU219595B (hu) 2001-05-28
AU3430495A (en) 1996-05-02
DE4437544A1 (de) 1996-04-25
US5571784A (en) 1996-11-05
PL311031A1 (en) 1996-04-29
ZA958838B (en) 1996-05-13
TW398977B (en) 2000-07-21
EP0713881A2 (de) 1996-05-29
NO954175D0 (no) 1995-10-19
CZ271995A3 (en) 1996-05-15
CN1128168A (zh) 1996-08-07
JPH08208504A (ja) 1996-08-13
EP0713881A3 (de) 1996-08-21
HUT73762A (en) 1996-09-30
HRP950525A2 (en) 1997-04-30
SK129695A3 (en) 1996-10-02
FI954964A0 (fi) 1995-10-18
NO954175L (no) 1996-04-22
HU9503031D0 (en) 1995-12-28
KR960013383A (ko) 1996-05-22
AU708670B2 (en) 1999-08-12
IL115652A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
AU5745290A (en) Improvements in or relating to medical ventilators
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
AU2260088A (en) Methods and compositions for the treatment of lung conditions
AU7327294A (en) Methods and articles for administering drug to the oral cavity
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
AU1283588A (en) New pharmaceutical compositions in the form of beadlets and method
EP0304802A3 (en) Pharmaceutical composition and the use thereof
IL115652A (en) Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages
AU2672795A (en) Benzopyrans and their use as therapeutic agents
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
HUP0003244A2 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU631334B2 (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines, and therapeutic compositions containing them
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
HUT50472A (en) Process for producing new condensed diazepinones and pharmaceutical compositions comprising the same
JPS6416790A (en) 6-substituted peneem ester as anti-inflammatory drug and anti-modifying agent
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
IL117179A (en) Substituted benzenesulfonylureas and-thioureas processes for their preparation and use thereof in the production of medicaments and pharmaceutical compositions containing them
GB9008215D0 (en) Improvements in or relating to the treatment of surfaces
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
AU8838291A (en) The use of carbazones as novel active ingredients in medicaments

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees